Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Konimex is Indonesia’s largest pharmaceutical manufacturer with a diversified portfolio including prescription/OTC medicines, food supplements, natural products, medical devices, personal care items and more. The company operates at commercial scale across Southeast Asia with strong regulatory compliance systems for serialization and supply chain traceability. It has expanded into dozens of countries over its 57-year history.[1][3][4]
No clinical trial results are published as the company focuses on manufacturing/distribution rather than novel drug development.
Key product lines include well-known consumer brands such as Konilife Omega 3 and Imunea.[5]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Konimex.